The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...

Discover OncoCyte's Q4 2024 progress with its cutting-edge kidney transplant test. Insights on FDA ambitions, market strategies & financial runway.

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

The conservative Pelican Institute has released a report outlining four ways to reduce criminal recidivism and thus make ...

Specific changes are needed to lower the barriers to entry for using the hospital and insurer price transparency data, ...

Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...

The company's objective was to assess the essential documentation for submission, determine the necessity of conducting ...

ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.

IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Jared Stanley, Chief Executive Officer, and Joel Stanley, ...

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, ...